Synthesis process of thiabendazole compound and bactericide
By simplifying the synthesis process of thibenebenzolaze, using carboxylic acid activators, oxidants and condensation reactions, the problems of cumbersome steps and low yields in the traditional process are solved, and efficient and environmentally friendly thibenebenzolaze synthesis is achieved, suitable for bactericides application.
Patent Information
- Application Number
- CN202410910536.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-08
- Publication Date
- 2024-11-15
AI Technical Summary
The traditional thiobenmidazole synthesis process has cumbersome steps, low production efficiency, environmental pollution and safety hazards of raw materials and solvents, and insufficient yield and purity, which limits its promotion in actual applications.
The thiazole ring-4-carboxylic acid is esterified by carboxylic acid activator, followed by oxidation treatment under the action of oxidant, followed by hydrolysis and acidification treatment under alkaline conditions, and finally condensation reaction with orthophenyldiamine, passing through the catalyst Purification gives thiobenmidazole of high yield and high purity.
The synthesis process is simplified, and the use of green and environmentally friendly raw materials and reagents is used to improve the yield and purity of thiobenmidazole, ensuring an efficient and environmentally friendly synthesis process, and is suitable for the wide application of fungicides.
Smart Images

Figure CN118955489A_ABST
Abstract
Description
Technical Field
[0001] The present application belongs to the technical field of organic synthesis, and in particular relates to a synthesis process and a fungicide of a thiabendazole compound. Background Art
[0002] In the field of pesticides and medicinal chemistry, benzimidazole compounds have attracted much attention due to their unique biological activity and broad application prospects. Among them, thiabendazole (thiabendazole fungicide), as an important benzimidazole compound, has excellent bactericidal effects in controlling a variety of fungal diseases and parasitic infections, and is widely used in agricultural production and medicine. Thiabendazole (thiabendazole) and its derivatives inhibit the synthesis of microtubules, block the division and proliferation of parasite cells, and thus exert antiparasitic effects. The unique mechanism of action of this type of compound makes it an indispensable drug in anti-infection treatment.
[0003] With the development of new synthetic methods and molecular modification technologies, more thiabendazole derivatives with improved efficacy and safety are being developed. The traditional thiabendazole synthesis process has many shortcomings. First, the traditional process usually involves multi-step reactions, cumbersome steps, and complex operations, resulting in low production efficiency. Secondly, the raw materials and solvents used in the traditional process often have environmental pollution and safety hazards, which do not meet the requirements of modern green chemistry. In addition, due to improper control of reaction conditions, the traditional process is prone to low product yield and poor purity, which limits its promotion in practical applications.
[0004] In order to overcome the shortcomings of traditional synthesis processes, researchers have been exploring new synthesis methods and optimizing process conditions. In recent years, with the continuous development of chemical synthesis technology and the popularization of the concept of green chemistry, people have begun to pay attention to the environmental protection, economy and efficiency of the synthesis process. At present, the synthesis of thiabendazole still faces challenges, including the complexity of its chemical structure requiring complex synthesis strategies, environmental problems caused by some reagents and solvents used, and the ongoing fight against antimicrobial resistance that weakens its efficacy. These challenges highlight the need for continued research on new synthetic methods. Therefore, it has become an urgent need to develop an efficient, environmentally friendly, and high-purity thiabendazole synthesis process. Summary of the invention
[0005] The purpose of the present application is to provide a synthesis process and fungicide of thiabendazole compounds, aiming to solve the problems of cumbersome steps, low yield and low purity in the synthesis process of thiabendazole compounds to a certain extent.
[0006] In order to achieve the above application purpose, the technical solution adopted in this application is as follows:
[0007] In a first aspect, the present application provides a synthesis process of a thiabendazole compound, comprising the following steps:
[0008] Using thiazole ring-4-carboxylic acid or thiazole ring-4-carboxylic acid derivatives as raw materials, esterifying the thiazole ring-4-carboxylic acid or the thiazole ring-4-carboxylic acid derivatives with a carboxylic acid activator to obtain thiazolidine-4-carboxylic acid methyl ester or thiazolidine-4-carboxylic acid methyl ester derivatives; wherein a substituent group is grafted on the thiazole ring of the thiazole ring-4-carboxylic acid derivatives;
[0009] Under the action of an oxidant, the thiazolidine-4-carboxylic acid methyl ester or the thiazolidine-4-carboxylic acid methyl ester derivative is subjected to an oxidation treatment to obtain thiazole-4-carboxylic acid methyl ester or a thiazole-4-carboxylic acid methyl ester derivative;
[0010] Under alkaline conditions, the thiazole-4-carboxylic acid methyl ester or the thiazole-4-carboxylic acid methyl ester derivative is hydrolyzed and then acidified to obtain thiazole-4-carboxylic acid or thiazole-4-carboxylic acid derivative;
[0011] Under the action of a catalyst, the thiazole-4-carboxylic acid or the thiazole-4-carboxylic acid derivative is subjected to a condensation reaction with o-phenylenediamine or an o-phenylenediamine derivative and a catalyst, and purified to obtain thiabendazole or a thiabendazole derivative; wherein a substituent is grafted onto the thiophene ring and / or the benzene ring in the thiabendazole derivative.
[0012] In some possible implementations, the carboxylic acid activating agent includes at least one of thionyl chloride, phosphorus chloride, sulfuryl chloride, hydrogen chloride, and sulfuric acid.
[0013] In some possible implementations, the solvent for the esterification treatment includes at least one of methanol, ethanol, and dimethyl sulfoxide.
[0014] In some possible implementations, the temperature of the esterification treatment is 0° C. to 65° C., and the reaction time is 4 to 24 hours.
[0015] In some possible implementations, the ratio of the thiazole ring-4-carboxylic acid or the thiazole ring-4-carboxylic acid derivative to the carboxylic acid activating agent is 1 g: (1-2) mL.
[0016] In some possible implementations, the esterification step includes: dissolving the thiazole ring-4-carboxylic acid in anhydrous methanol, cooling in an ice bath to 0°C to 5°C, adding dropwise the thionyl chloride for mixing for 1 to 2 hours, removing the ice bath and continuing mixing for 4 to 24 hours.
[0017] In some possible implementations, the oxidant includes at least one of manganese dioxide, N-methylmorpholine-N-oxide, and potassium permanganate.
[0018] In some possible implementations, the oxidant is activated at 300° C. to 500° C. before the oxidation treatment is performed.
[0019] In some possible implementations, the solvent for the oxidation treatment includes at least one of acetonitrile, dimethyl sulfoxide, and methanol.
[0020] In some possible implementations, the oxidation treatment temperature is 75° C. to 85° C., and the reaction time is 4 to 48 hours.
[0021] In some possible implementations, the molar ratio of the thiazolidine-4-carboxylic acid methyl ester or the thiazolidine-4-carboxylic acid methyl ester derivative to the oxidant is 1:(20-25).
[0022] In some possible implementations, the oxidation treatment step includes: dissolving the manganese dioxide activated at 300° C. to 400° C. and the thiazolidine-4-carboxylic acid methyl ester in acetonitrile, reacting at a temperature of 75° C. to 85° C. for 24 to 48 hours, filtering after cooling, and removing the solvent in the filtrate to obtain the thiazole-4-carboxylic acid methyl ester.
[0023] In some possible implementations, the pH value of the alkaline condition is 7-9.
[0024] In some possible implementations, the temperature of the hydrolysis treatment is 20° C. to 40° C., and the reaction time is 1 to 2 hours.
[0025] In some possible implementations, the solvent for the hydrolysis treatment includes at least one of methanol and ethanol.
[0026] In some possible implementations, the acidification step includes: adding hydrochloric acid and mixing, and then performing extraction to obtain the thiazole-4-carboxylic acid.
[0027] In some possible implementations, the extractant used in the extraction treatment includes at least one of diethyl ether, dioxane, and n-hexane.
[0028] In some possible implementations, the step of preparing the thiazole-4-carboxylic acid includes: dissolving the thiazole-4-carboxylic acid methyl ester in methanol, adding 10% by mass of sodium hydroxide to adjust the pH value to 7-9, and then mixing for 1-2 hours, adding concentrated hydrochloric acid and mixing, and then using diethyl ether to extract, separate and purify the product to obtain the thiazole-4-carboxylic acid.
[0029] In some possible implementations, the catalyst includes at least one of polyphosphoric acid, pyridine, and piperidine.
[0030] In some possible implementations, the molar ratio of the thiazole-4-carboxylic acid or the thiazole-4-carboxylic acid derivative to the o-phenylenediamine or the o-phenylenediamine derivative to the catalyst is 1:(0.8-1.2):(0.5-0.7).
[0031] In some possible implementations, the condensation reaction step includes: in an inert atmosphere, mixing the o-phenylenediamine and the catalyst and preheating the mixture to 120° C. to 180° C., adding the thiazole-4-carboxylic acid and heating the mixture to 200° C. to 250° C. for reaction.
[0032] In some possible implementations, the purification step includes: adjusting the pH value of the product of the condensation reaction to 5-6 to precipitate a crude product, dissolving the crude product in an acid solution with a pH value of 1-2 after washing, adding activated carbon for decolorization, adjusting the pH value of the filtrate to 7-8 after filtering, collecting the crystalline product, and obtaining the thiabendazole.
[0033] In some possible implementations, the yield of the thiabendazole is not less than 85%, and the purity is not less than 99%.
[0034] In a second aspect, the present application provides a fungicide, wherein the fungicide contains thiabendazole and / or thiabendazole derivatives obtained by the above-mentioned synthesis process.
[0035] The synthesis process of thiabendazole compounds provided in the first aspect of the present application is based on thiazole ring-4-carboxylic acid or thiazole ring-4-carboxylic acid derivatives as raw materials, and after being converted into thiazolidine-4-carboxylic acid methyl ester or thiazolidine-4-carboxylic acid methyl ester derivatives by using a carboxylic acid activator, oxidation and hydrolysis treatment are carried out, and further converted into thiazole-4-carboxylic acid or thiazole-4-carboxylic acid derivatives. Then, under the action of a catalyst, thiabendazole or thiabendazole derivatives are purified by condensation reaction with o-phenylenediamine. The synthesis process is simplified, the conditions are mild, and the raw materials and reagents are green and environmentally friendly. And by controlling each reaction step, the by-product generation can be reduced, the yield and purity of the target product of thiabendazole or thiabendazole derivatives are improved, and the final product with high yield and high purity is ensured. This application explores new synthetic routes for thiabendazole or thiabendazole derivatives, improves product yield and purity without affecting efficacy, and at the same time considers environmental sustainable development, utilizes green chemistry principles, optimizes the synthetic process, improves the efficiency and sustainability of the synthetic process of thiabendazole or thiabendazole derivatives, and reduces the impact on the environment.
[0036] The thiabendazole and / or thiabendazole derivatives prepared as described above in the present application have excellent bactericidal effects and are applied in bactericides, and can be widely used for sterilization in agricultural production and the medical field. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] In order to more clearly illustrate the technical solutions in the embodiments of the present application, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.
[0038] Figure 1 Schematic diagram of the synthesis process of thiabendazole compounds provided in the examples of the present application;
[0039] Figure 2 is a schematic flow diagram of the synthesis process of thiabendazole provided in Example 1 of the present application;
[0040] Figure 3 is the NMR spectrum of thiazolidine-4-carboxylic acid methyl ester provided in Example 1 of the present application;
[0041] Figure 4 is the NMR spectrum of thiazole-4-carboxylic acid provided in Example 1 of the present application;
[0042] Figure 5 This is the NMR spectrum of thiabendazole provided in Example 1 of the present application. DETAILED DESCRIPTION
[0043] In order to make the technical problems, technical solutions and beneficial effects to be solved by the present application more clearly understood, the present application is further described in detail below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present application and are not used to limit the present application.
[0044] In this application, the term "and / or" describes the association relationship of associated objects, indicating that there may be three relationships. For example, A and / or B can mean: A exists alone, A and B exist at the same time, and B exists alone. A and B can be singular or plural. The character " / " generally indicates that the associated objects are in an "or" relationship.
[0045] In this application, "at least one" means one or more, and "plurality" means two or more. "At least one of the following" or similar expressions refers to any combination of these items, including any combination of single items or plural items. For example, "at least one of a, b or c", or "at least one of a, b and c", can all represent: a, b, c, ab (i.e. a and b), ac, bc, or abc, where a, b, c can be single or multiple, respectively.
[0046] It should be understood that in the various embodiments of the present application, the size of the serial numbers of the above-mentioned processes does not mean the order of execution, some or all of the steps can be executed in parallel or sequentially, and the execution order of each process should be determined by its function and internal logic, and should not constitute any limitation on the implementation process of the embodiments of the present application.
[0047] The terms used in the embodiments of the present application are only for the purpose of describing specific embodiments, and are not intended to limit the present application. The singular forms "a", "an" and "the" used in the embodiments of the present application and the appended claims are also intended to include plural forms, unless the context clearly indicates other meanings.
[0048] The weight of the relevant components mentioned in the embodiments of the present specification can not only refer to the specific content of each component, but also represent the proportional relationship between the weights of the components. Therefore, as long as the content of the relevant components in the embodiments of the present specification is proportionally enlarged or reduced, it is within the scope disclosed in the embodiments of the present specification. Specifically, the mass described in the embodiments of the present specification can be μg, mg, g, kg and other mass units known in the chemical industry.
[0049] The terms "first" and "second" are used only for descriptive purposes to distinguish objects such as substances from each other, and should not be understood as indicating or implying relative importance or implicitly indicating the number of indicated technical features. For example, without departing from the scope of the embodiments of the present application, the first XX may also be referred to as the second XX, and similarly, the second XX may also be referred to as the first XX. Thus, the features defined as "first" and "second" may explicitly or implicitly include one or more of the features.
[0050] The first aspect of the present application provides a synthesis process of thiabendazole compounds, as shown in the attached Figure 1 As shown, the following steps are included:
[0051] S10. Using thiazole ring-4-carboxylic acid or thiazole ring-4-carboxylic acid derivatives as raw materials, esterifying thiazole ring-4-carboxylic acid or thiazole ring-4-carboxylic acid derivatives with a carboxylic acid activator to obtain thiazolidine-4-carboxylic acid methyl ester or thiazolidine-4-carboxylic acid methyl ester derivatives; wherein a substituent group is grafted onto the thiazole ring in the thiazole ring-4-carboxylic acid derivatives;
[0052] S20. Under the action of an oxidant, thiazolidine-4-carboxylic acid methyl ester or a thiazolidine-4-carboxylic acid methyl ester derivative is oxidized to obtain thiazole-4-carboxylic acid methyl ester or a thiazole-4-carboxylic acid methyl ester derivative;
[0053] S30. Under alkaline conditions, hydrolyzing thiazole-4-carboxylic acid methyl ester or thiazole-4-carboxylic acid methyl ester derivative, and then acidifying to obtain thiazole-4-carboxylic acid or thiazole-4-carboxylic acid derivative;
[0054] S40. In the presence of a catalyst, thiazole-4-carboxylic acid or a thiazole-4-carboxylic acid derivative is subjected to a condensation reaction with o-phenylenediamine or an o-phenylenediamine derivative and a catalyst, followed by purification to obtain thiabendazole or a thiabendazole derivative; wherein a substituent is grafted onto the thiophene ring and / or the benzene ring in the thiabendazole derivative.
[0055] The synthesis process of thiabendazole compounds provided in the first aspect of the embodiment of the present application is based on thiazole ring-4-carboxylic acid or thiazole ring-4-carboxylic acid derivatives as raw materials, and after being converted into thiazolidine-4-carboxylic acid methyl ester or thiazolidine-4-carboxylic acid methyl ester derivatives by using a carboxylic acid activator, oxidation and hydrolysis treatment are carried out, and further converted into thiazole-4-carboxylic acid or thiazole-4-carboxylic acid derivatives. Then, under the action of a catalyst, thiabendazole or thiabendazole derivatives are purified by condensation reaction with o-phenylenediamine. The synthesis process is simplified, the conditions are mild, and the raw materials and reagents are green and environmentally friendly. And by optimizing the reaction steps and conditions, the yield and purity of each step of the reaction are significantly improved, thereby improving the overall synthesis efficiency, reducing the generation of by-products, and improving the yield and purity of the target product of thiabendazole or thiabendazole derivatives, ensuring a high yield and high purity final product. The embodiments of the present application explore new synthetic routes for thiabendazole or thiabendazole derivatives, thereby improving product yield and purity without affecting drug efficacy. Meanwhile, the sustainable development of the environment is taken into consideration, the principles of green chemistry are utilized, the synthetic process is optimized, the efficiency and sustainability of the synthetic process of thiabendazole or thiabendazole derivatives are improved, and the risk of environmental pollution is reduced.
[0056] In the above step S10: thiazole ring-4-carboxylic acid or thiazole ring-4-carboxylic acid derivatives are used as raw materials, wherein the chemical formula of thiazole ring-4-carboxylic acid is Thiazole ring-4-carboxylic acid derivatives have a substituent group grafted onto the thiazole ring, and its chemical formula can be Wherein R1 and R2 are independently alkyl, alkenyl, hydrocarbon, halogen, aryl or the like.
[0057] In some possible implementations, thiazole ring-4-carboxylic acid is esterified with a carboxylic acid activator to obtain thiazolidine-4-carboxylic acid methyl ester. Alternatively, thiazole ring-4-carboxylic acid derivatives are esterified with a carboxylic acid activator to obtain thiazolidine-4-carboxylic acid methyl ester derivatives.
[0058] In some possible implementations, the carboxylic acid activator includes at least one of thionyl chloride, phosphorus chloride, sulfuryl chloride, hydrogen chloride, and sulfuric acid. These carboxylic acid activators can activate the carboxylic acid in the thiazole ring-4-carboxylic acid or thiazole ring-4-carboxylic acid derivatives, and undergo an intramolecular nucleophilic substitution reaction to generate thiazolidine-4-carboxylic acid methyl ester or thiazolidine-4-carboxylic acid methyl ester derivatives.
[0059] In some embodiments, the carboxylic acid activator includes thionyl chloride, which can convert thiazolidine-4-carboxylic acid into formate at relatively low temperatures and simple conditions. Moreover, thionyl chloride not only improves the overall efficiency of the reaction, but also optimizes the convenience of operation, making the entire reaction process more gentle and selective, greatly reducing the occurrence of side reactions, and environmentally friendly. The reaction can be completed at a relatively low temperature, while reducing the risk of decomposition of sensitive substances, and avoiding the possibility of affecting other functional groups. In addition, from the perspective of safety and environment, the use of thionyl chloride greatly reduces the harm to the experimental environment, because it is safer than other chlorination reagents, and its byproducts are easier to handle, and the impact on the environment is relatively small.
[0060] In some possible implementations, the solvent for the esterification treatment includes at least one of methanol, ethanol, and dimethyl sulfoxide. In this case, the solvent has a good dissolving effect on the thiazole ring-4-carboxylic acid, the thiazole ring-4-carboxylic acid derivative, and the carboxylic acid activator, provides a solvent environment for the reaction between the components, and is environmentally friendly.
[0061] In some possible implementations, the temperature of the esterification treatment is 0° C. to 65° C., and the reaction time is 4 to 24 hours. Under such reaction conditions, the esterification treatment is favorable for generating thiazolidine-4-carboxylic acid methyl ester or thiazolidine-4-carboxylic acid methyl ester derivatives.
[0062] In some possible implementations, the ratio of thiazole ring-4-carboxylic acid or thiazole ring-4-carboxylic acid derivative to carboxylic acid activator is 1 g: (1-2) mL. Under this ratio, the activation effect of the carboxylic acid activator on the carboxylic acid in thiazole ring-4-carboxylic acid or thiazole ring-4-carboxylic acid derivative is fully ensured to obtain thiazolidine-4-carboxylic acid methyl ester or thiazolidine-4-carboxylic acid methyl ester derivative, and reduce the generation of by-products.
[0063] In some possible implementations, the esterification step includes: dissolving thiazole ring-4-carboxylic acid in anhydrous methanol, cooling to 0°C to 5°C in an ice bath, adding thionyl chloride dropwise for mixing for 1 to 2 hours, removing the ice bath and continuing to mix for 4 to 24 hours. In this case, the selection of reaction raw materials, reaction conditions and thionyl chloride not only ensures high yield and purity, but also its operation process is simple, safe, and has little burden on the environment. This choice provides important reference value for ensuring the reliability of experimental results and for future large-scale production. At this time, the yield of thiazolidine-4-carboxylic acid methyl ester reaches 92%. Its reaction equation is as follows 1:
[0064]
[0065] In the above step S20: methyl thiazolidine-4-carboxylate or methyl thiazolidine-4-carboxylate derivative is subjected to oxidation treatment under the action of an oxidant to obtain methyl thiazolidine-4-carboxylate or methyl thiazolidine-4-carboxylate derivative. In some possible implementations, methyl thiazolidine-4-carboxylate is subjected to oxidation treatment to obtain methyl thiazolidine-4-carboxylate. Alternatively, methyl thiazolidine-4-carboxylate derivative is subjected to oxidation treatment to obtain methyl thiazolidine-4-carboxylate derivative.
[0066] In some possible implementations, the oxidant includes at least one of manganese dioxide, N-methylmorpholine-N-oxide, and potassium permanganate. In this case, these oxidants are all capable of oxidizing thiazolidine-4-carboxylic acid methyl ester or thiazolidine-4-carboxylic acid methyl ester derivatives to thiazole-4-carboxylic acid methyl ester or thiazole-4-carboxylic acid methyl ester derivatives.
[0067] In some embodiments, the oxidant includes manganese dioxide, which is a mild oxidant that has the ability to selectively oxidize primary and secondary alcohols. It can promote the oxidation of the thiazole ring under mild conditions, mild reaction temperature and avoid local overheating, reduce side reactions, and is environmentally friendly.
[0068] In some possible implementations, the oxidant is activated at 300° C. to 500° C. before being oxidized. In this case, the oxidant activated at high temperature has a better oxidation effect. The oxidant has better oxidation performance at this activation temperature.
[0069] In some embodiments, the effectiveness of manganese dioxide at different activation temperatures was studied, and the specific yield changes were recorded. It was found that the increase in activation temperature can increase the yield of the reaction, but this increase tends to be flat after reaching a certain temperature. The activation treatment of manganese dioxide at 300°C to 500°C not only makes the oxidant have better oxidation performance, but is also more economical and energy-saving.
[0070] In some embodiments, 100 ℃ activated manganese dioxide gives a lower yield, about 50%. As the activation temperature rises to 200 ℃, the yield is increased to 65%, showing the effect of temperature on the activation state. When the activation temperature is further increased to 300 ℃, the yield reaches the optimum, which is 80.8%. This shows that a higher activation temperature can increase the active sites of manganese dioxide, thereby improving catalytic efficiency. For manganese dioxide activated at 400 ℃ and 500 ℃, although they may slightly increase the yield, considering that the increase in yield is not significant, and for the economic and energy-saving considerations of the experiment, 300 ℃ is selected as the preferred activation temperature of manganese dioxide.
[0071] In some possible implementations, the solvent for the oxidation treatment includes at least one of acetonitrile, dimethyl sulfoxide, and methanol. These solvents have a good dissolving effect on the oxidant and thiazolidine-4-carboxylic acid methyl ester or thiazolidine-4-carboxylic acid methyl ester derivatives, provide a suitable solvent reaction for the oxidation reaction, and are environmentally friendly.
[0072] In some possible implementations, the oxidation treatment temperature is 75° C. to 85° C., and the reaction time is 4 to 48 hours. The oxidation conditions are mild, avoiding side reactions caused by excessively high temperatures.
[0073] In some possible implementations, the molar ratio of thiazolidine-4-carboxylic acid methyl ester or thiazolidine-4-carboxylic acid methyl ester derivative to the oxidant is 1:(20-25). Under this ratio, the oxidation effect of the oxidant on thiazolidine-4-carboxylic acid methyl ester or thiazolidine-4-carboxylic acid methyl ester derivative is fully ensured.
[0074] In some possible implementations, the oxidation treatment step includes: dissolving manganese dioxide activated at 300°C to 400°C and thiazolidine-4-carboxylic acid methyl ester in acetonitrile (ACN), reacting at a temperature of 75°C to 85°C for 24 to 48 hours, filtering after cooling, removing the solvent in the filtrate, and obtaining thiazole-4-carboxylic acid methyl ester. In this case, by the specific selection of the oxidant and its activation conditions, solvent, reaction temperature and duration, the yield of thiazole-4-carboxylic acid methyl ester is significantly improved, the formation of by-products is reduced, and the purity of thiazole-4-carboxylic acid methyl ester is improved. The yield of thiazole-4-carboxylic acid methyl ester reaches 80.8%. Its reaction equation is as follows:
[0075]
[0076] In the above step S30: under alkaline conditions, thiazole-4-carboxylic acid methyl ester or thiazole-4-carboxylic acid methyl ester derivative is hydrolyzed to ensure that the methyl ester can be completely converted into the desired carboxylic acid, and then acidification is performed to hydrolyze the acid anhydride to form a carboxylic acid to obtain thiazole-4-carboxylic acid or thiazole-4-carboxylic acid derivative.
[0077] In some embodiments, thiazole-4-carboxylic acid methyl ester is hydrolyzed under alkaline conditions and then acidified to obtain thiazole-4-carboxylic acid. Alternatively, thiazole-4-carboxylic acid methyl ester derivatives are hydrolyzed under alkaline conditions and then acidified to obtain thiazole-4-carboxylic acid derivatives.
[0078] In some possible implementations, the pH value of the alkaline condition is 7-9; under this pH value condition, thiazole-4-carboxylic acid methyl ester or thiazole-4-carboxylic acid methyl ester derivatives have a good hydrolysis effect, ensuring that the methyl ester can be completely converted into the desired carboxylic acid.
[0079] In some embodiments, a solution of sodium hydroxide having a mass percentage concentration of 10% is used to adjust the pH value of the reaction system, while noting that the 10% sodium hydroxide should be added in a controlled manner to avoid local over-alkaline conditions, which may cause unwanted side reactions.
[0080] In some possible implementations, the hydrolysis treatment temperature is 20° C. to 40° C., and the reaction time is 1 to 2 hours. In this case, the hydrolysis treatment conditions are mild, can be carried out at room temperature, has few by-products, and has high product purity.
[0081] In some possible implementations, the solvent for the hydrolysis treatment includes at least one of methanol and ethanol. These solvents have a good dissolving effect on thiazole-4-carboxylic acid methyl ester or thiazole-4-carboxylic acid methyl ester derivatives, are conducive to the hydrolysis treatment, and are environmentally friendly.
[0082] In some possible implementations, the acidification step includes: adding hydrochloric acid and mixing, hydrolyzing the acid anhydride to form carboxylic acid, and then performing extraction treatment to obtain thiazole-4-carboxylic acid.
[0083] In some possible implementations, the extractant used in the extraction process includes at least one of diethyl ether, dioxane, and n-hexane. These extractants have good extraction effects on the reaction products. Among them, the extraction efficiency of diethyl ether can reach 90%. The high polarity of diethyl ether enables it to effectively dissolve thiazole-4-carboxylic acid, and its good volatility also facilitates the rapid removal of the solvent from the mixture during the purification of the product after extraction, thereby reducing the risk of thermal degradation of the product and improving the purity of the product. When dioxane is used as an extraction solvent, the yield drops to about 70%. Although dioxane shows good performance as a non-polar solvent in extracting non-polar compounds, due to the polar carboxyl group contained in thiazole-4-carboxylic acid, this causes the solubility of dioxane to be inferior to that of diethyl ether. In addition, although the low volatility of dioxane is an advantage in some cases, it may become a limiting factor when the solvent needs to be removed quickly to avoid possible side reactions. The extraction yield of n-hexane is about 65%. The non-polar properties of n-hexane make it less efficient in extracting less polar organic compounds, especially when the target compound, such as thiazole-4-carboxylic acid, has significant polarity. Although n-hexane has a moderate evaporation rate, which is conducive to solvent recovery, its solubility for polar carboxylic acids is not sufficient to support a high extraction yield.
[0084] In some possible implementations, the steps of preparing thiazole-4-carboxylic acid include: dissolving thiazole-4-carboxylic acid methyl ester in methanol, adding 10% sodium hydroxide by mass to adjust the pH value to 7-9, mixing for 1-2 hours, adding concentrated hydrochloric acid and mixing, and extracting and separating the purified product with diethyl ether to obtain thiazole-4-carboxylic acid. In this case, the yield and purity of thiazole-4-carboxylic acid are significantly improved by comprehensive optimization of the solvent, alkaline reagent and its concentration, hydrolysis pH, acidification conditions, and extraction conditions, and the yield reaches 90%. The reaction equation is as follows:
[0085]
[0086] In the above step S40: in the presence of a catalyst, thiazole-4-carboxylic acid or a thiazole-4-carboxylic acid derivative is subjected to a condensation reaction with o-phenylenediamine or an o-phenylenediamine derivative and a catalyst to generate a final fused ring compound. That is, thiazole-4-carboxylic acid is subjected to a condensation reaction with o-phenylenediamine and a catalyst; or, thiazole-4-carboxylic acid is subjected to a condensation reaction with an o-phenylenediamine derivative and a catalyst; or, thiazole-4-carboxylic acid derivative is subjected to a condensation reaction with o-phenylenediamine and a catalyst; or, thiazole-4-carboxylic acid derivative is subjected to a condensation reaction with o-phenylenediamine derivative and a catalyst.
[0087] In some embodiments, the chemical formula of the o-phenylenediamine derivative can be Among them, R3, R4, R5, and R6 are independently alkyl, alkenyl, hydrocarbon, halogen, aryl, and the like.
[0088] In some embodiments, the chemical formula of the thiabendazole derivative can be or or In each chemical formula, R1, R2, R3, R4, R5, and R6 are independently an alkyl group, an alkenyl group, a hydrocarbon group, a halogen group, an aryl group, or the like.
[0089] In some possible implementations, the catalyst includes at least one of polyphosphoric acid, pyridine, and piperidine. These catalysts can catalyze the condensation of thiazole-4-carboxylic acid or thiazole-4-carboxylic acid derivatives with o-phenylenediamine or o-phenylenediamine derivatives to generate condensed ring compounds.
[0090] In some specific embodiments, the catalyst includes polyphosphoric acid, which not only acts as a catalyst but also provides a highly acidic environment to promote the dehydration and cyclization processes and is environmentally friendly.
[0091] In some possible implementations, the molar ratio of thiazole-4-carboxylic acid or thiazole-4-carboxylic acid derivatives to o-phenylenediamine or o-phenylenediamine derivatives and catalyst is 1: (0.8-1.2): (0.5-0.7). Under this ratio, the condensation reaction between thiazole-4-carboxylic acid or thiazole-4-carboxylic acid derivatives and o-phenylenediamine or o-phenylenediamine derivatives is ensured, while the possible polymerization side reactions are minimized.
[0092] In some possible implementations, the condensation reaction step includes: in an inert atmosphere, mixing o-phenylenediamine with a catalyst such as polyphosphoric acid (PPA) and preheating to 120°C to 180°C, adding thiazole-4-carboxylic acid and heating to 200°C to 250°C for reaction. Under the reaction conditions, preheating to the reaction temperature is necessary for the formation of active intermediates, which is more conducive to the full and thorough progress of the condensation reaction, ensuring the rapid progress of the condensation reaction, reducing the production of by-products, and improving the yield and purity of the product. The reaction equation is as follows V:
[0093]
[0094] In some possible implementations, the purification step includes: adjusting the pH value of the product of the condensation reaction to 5-6 to precipitate a crude product, dissolving the crude product in an acid solution with a pH value of 1-2 after washing, adding activated carbon for decolorization, adjusting the pH value of the filtrate to 7-8 after filtering, collecting the crystalline product, and obtaining thiabendazole. In this case, the purity and yield of the product are improved by strict control of the pH conditions. The pH control of the reaction plays a vital role in the whole process. During the purification process, by adjusting the pH value to 5-6, the product can be efficiently precipitated, which not only promotes the precipitation of the product, but also protects the structural integrity of the product by avoiding over-alkaline or over-acid conditions, thereby improving the purity of the product. Then adjusting the pH to 1-2 and adding activated carbon for decolorization are key steps to ensure the purity of the final product, which significantly improves the appearance and purity of the final product. Finally, adjusting the pH to 7-8 further ensures the crystallization of the product, which shows the importance of pH value in the morphology and purification process of the product.
[0095] In some possible implementations, the yield of thiabendazole is not less than 85%, and the purity is not less than 99%. The synthesis yield of thiabendazole in the embodiment of the present application is high, the purity is high, and the raw materials and reagents used are all environmentally friendly substances, which reduces the risk of environmental pollution and has higher practicality.
[0096] In a second aspect, an embodiment of the present application provides a fungicide, wherein the fungicide contains thiabendazole and / or thiabendazole derivatives obtained by the above-mentioned synthesis process.
[0097] The thiabendazole and / or thiabendazole derivatives prepared in the above embodiments of the present application have excellent bactericidal effects and are applied in bactericides, and can be widely used for sterilization in agricultural production and the medical field.
[0098] In order to enable those skilled in the art to clearly understand the implementation details and operations of the present application, and to demonstrate the significant improvement in the performance of the synthesis process of the thiabendazole compounds in the embodiments of the present application, the above technical scheme is illustrated by multiple embodiments below.
[0099] Example 1
[0100] A synthesis process of thiabendazole, as shown in the following Figure 2 As shown, the following steps are included:
[0101] 1. Dissolve thiazolidine-4-carboxylic acid (1.3 g, 9.59 mmol) in anhydrous methanol (19.18 mL) and cool to 0°C in an ice bath. Add thionyl chloride (1.40 mL, 19.18 mmol) dropwise and stir to react for 1 hour. Remove the ice bath and continue stirring for 4-5 hours or overnight. Strip the solvent and place the product under high vacuum to obtain 1.32 g of thiazolidine-4-carboxylic acid methyl ester (B-06) with a yield of 92% as a white solid. The NMR spectrum of thiazolidine-4-carboxylic acid methyl ester is shown in the attached figure. Figure 3 shown.
[0102] 2. Add thiazolidine-4-carboxylic acid methyl ester (3.0 g, 0.02 mol, 1.0 eq.), 175 mL acetonitrile, and 300°C activated MnO2 (40 g, 0.46 mol, 23 eq.) into a 250 mL four-necked flask, and react at 80°C for 48 h (GC tracking the reaction progress). After cooling, filter, and distill the filtrate under reduced pressure to remove the solvent to obtain 2.36 g of thiazole-4-carboxylic acid methyl ester (B-07), with a yield of 80.8%.
[0103] 3. Dissolve thiazole-4-carboxylic acid methyl ester (1.7 g) in methanol (15 mL) and treat with 1N sodium hydroxide (16 mL). After stirring at room temperature for 1 hour, treat the reactant with concentrated hydrochloric acid (1.5 mL) and concentrate under reduced pressure. The obtained turbid aqueous layer is extracted twice with diethyl ether, and the collected organic layers are dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain the desired compound, thiazole-4-carboxylic acid 1.38 g (B-08) as a white solid, with a yield of 90%. The NMR spectrum of thiazole-4-carboxylic acid is shown in the attached figure. Figure 4 shown.
[0104] 4. Add o-phenylenediamine (10.8g, 0.1mol, 1.0eq.) and polyphosphoric acid (21g, 0.062mol, 0.62eq.) to the reaction bottle, protect with nitrogen, and quickly heat the oil bath to 150 degrees Celsius under stirring, then add thiazole-4-carboxylic acid (12.9g, 0.1mol, 1.0eq.), raise the temperature to 230 degrees Celsius, and react for 2 hours. Stop the reaction after the TLC plate detects that the reaction is complete, cool it slightly, and pour it into 200 grams of ice-water mixture while hot. The mixture becomes a dark brown liquid. Neutralize it with 40% sodium hydroxide solution to pH = 6, and a large amount of purple-gray solid precipitates. Filter it and wash it with 20mL*4 water to obtain a purple-gray solid, that is, crude thiabendazole. The crude product was dissolved in 10 times the mass of water, adjusted to pH = 1-2 with dilute hydrochloric acid, and activated carbon was added for reflux decolorization, filtered, and the filtrate was heated to a weakly alkaline pH with a saturated sodium bicarbonate aqueous solution (pH = 7-8), then filtered and dried to obtain 17.7 g of a white crystalline solid, namely thiabendazole (B-04), with a yield of 88%. The NMR spectrum of thiabendazole is shown in the attached figure. Figure 5 shown.
[0105] Example 2
[0106] To explore the effect of carboxylic acid activating agent on the yield of methyl thiazolidine-4-carboxylate. The thionyl chloride (SOCl2) in step 1 of Example 1 was replaced with phosphorus chloride (PCl3 / PCl5), sulfuryl chloride (SO2Cl2), hydrogen chloride (HCl) and sulfuric acid (H2SO4) to explore the effect of carboxylic acid activating agent on the yield of methyl thiazolidine-4-carboxylate. The test results of the yield of methyl thiazolidine-4-carboxylate are shown in Table 1 below:
[0107] Table 1
[0108]
[0109] It can be seen from the above test results that thionyl chloride shows high efficiency and can convert thiazolidine-4-carboxylic acid into formate at a lower temperature and simple conditions, and finally obtains a white solid product with a yield of 92%. Thionyl chloride not only improves the overall efficiency of the reaction, but also optimizes the convenience of operation, making the entire reaction process more gentle and selective, and greatly reducing the occurrence of side reactions. This means that the reaction can be completed at a lower temperature, while reducing the risk of decomposition of sensitive substances and avoiding the possibility of affecting other functional groups. From the perspective of safety and environment, the use of thionyl chloride greatly reduces the harm to the experimental environment because it is safer than other chlorination reagents, and its by-products are easier to handle and have relatively little impact on the environment.
[0110] Relatively speaking, phosphorus chloride has a slightly lower yield of 80%. Although it is also a powerful chlorination agent, it requires extreme caution during the handling process because it is very reactive and its price is relatively high. Sulfuryl chloride is another effective chlorination agent. The results of its use show that the yield is about 72%, but it releases sulfur dioxide during the reaction, which poses a potential hazard to experimenters and the environment. Hydrogen chloride performed the least well in the experiment, with a yield of only 51%. It usually requires strong acidic conditions, which may cause problems in the handling of some sensitive compounds. In addition, sulfuric acid, as a traditional catalyst, is often used in esterification, but it is not a direct chlorination agent. Sulfuric acid can promote the esterification of methanol and carboxylic acids, but its application in this experiment shows that sulfuric acid is not effective in the direct chlorination of carboxylic acids and may cause side reactions and product purity problems.
[0111] Example 3
[0112] To study the effect of pH value on the precipitation effect of crude thiabendazole, the dark brown liquid after the condensation reaction in step 4 of Example 1 was adjusted to pH 3, 5, 6, 7, and 9 with 40% sodium hydroxide solution, and the effect of pH value on the yield of thiabendazole product was observed. The test results are shown in Table 2 below:
[0113] Table 2
[0114]
[0115] From the above test results, it can be seen that when the pH value is 3, the synthesis yield is 72%. As the pH value increases to 5, the yield decreases to 65%. When the pH value is further increased to 6, the yield increases to 88%. However, when the pH value is adjusted to 7, the yield drops slightly to 80%. Finally, when the pH value is 9, the yield of the synthesis drops again to 75%. From these data, we can see that both lower pH values (acidic conditions) and higher pH values (alkaline conditions) are not conducive to the highest yield of the product. When the pH value is in the middle range (for example, pH 6), a peak in the synthesis yield is observed. This may be because at medium pH values, the reaction conditions are conducive to the formation of the target compound and reduce possible side reactions. Overly acidic or overly basic conditions may affect the stability of the intermediate or change the activity of the catalyst, resulting in fluctuations in the yield.
[0116] Example 4
[0117] A synthesis process of thiabendazole, in which the amount of raw materials and reaction conditions are adjusted. 60 g of thiazole ring-4-carboxylic acid, 120 ml of thionyl chloride and 60 ml of methanol are used for esterification. In the oxidation step, 120 g of manganese dioxide and 400 ml of acetonitrile are used and reacted at 75°C for 5 hours. The conditions of the hydrolysis step and the condensation reaction are the same as those in Example 1. The final thiabendazole has a purity of 99.0% and a yield of 90%.
[0118] Example 5
[0119] A synthesis process of thiabendazole. In order to explore the effect of different solvents on the reaction, ethanol was used instead of methanol in the esterification step. The specific operation is: 50 grams of thiazole ring-4-carboxylic acid is mixed with 100 milliliters of thionyl chloride and 50 milliliters of ethanol, and reacted at 65°C for 2.5 hours. The subsequent oxidation, hydrolysis and condensation reaction conditions are the same as those in Example 1. The final thiabendazole has a purity of 98.8% and a yield of 87%.
[0120] Example 6
[0121] A synthesis process of thiabendazole, in which the amount of the oxidant is changed. In the oxidation step, 80 grams of manganese dioxide is used as the oxidant, and other conditions are kept the same as those in Example 1. The purity of the finally obtained thiabendazole is 99.1%, and the yield is 89%.
[0122] Example 7
[0123] A synthesis process of thiabendazole, in order to optimize the conditions of the condensation reaction, different amounts of polyphosphoric acid are used in this step. The specific operation is: in the condensation reaction, polyphosphoric acid with a molar amount of 1.2 times that of thiazole-4-carboxylic acid is added, and other conditions are kept the same as those in Example 1. The purity of the finally obtained thiabendazole is 99.3%, and the yield is 91%.
[0124] By comparing the above-mentioned Example 1 with Examples 4 to 7, it can be seen that different raw material dosages and reaction conditions in the efficient synthesis process of thiabendazole and its derivatives will affect the product purity and yield to a certain extent. By adjusting these parameters, the synthesis process can be further optimized to improve the quality and yield of the product. The yield of thiabendazole in the embodiment of the present application is as high as 90%, and the purity is not less than 99%.
[0125] The above description is only a preferred embodiment of the present application and is not intended to limit the present application. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present application should be included in the protection scope of the present application.
Claims
1. A synthesis process of thiabendazole compounds, characterized in that: The following steps are involved: Using thiazole ring-4-carboxylic acid or thiazole ring-4-carboxylic acid derivatives as raw materials, esterifying the thiazole ring-4-carboxylic acid or the thiazole ring-4-carboxylic acid derivatives with a carboxylic acid activator to obtain thiazolidine-4-carboxylic acid methyl ester or thiazolidine-4-carboxylic acid methyl ester derivatives; wherein a substituent group is grafted on the thiazole ring of the thiazole ring-4-carboxylic acid derivatives; Under the action of an oxidant, the thiazolidine-4-carboxylic acid methyl ester or the thiazolidine-4-carboxylic acid methyl ester derivative is subjected to an oxidation treatment to obtain thiazole-4-carboxylic acid methyl ester or a thiazole-4-carboxylic acid methyl ester derivative; Under alkaline conditions, the thiazole-4-carboxylic acid methyl ester or the thiazole-4-carboxylic acid methyl ester derivative is hydrolyzed and then acidified to obtain thiazole-4-carboxylic acid or thiazole-4-carboxylic acid derivative; Under the action of a catalyst, the thiazole-4-carboxylic acid or the thiazole-4-carboxylic acid derivative is subjected to a condensation reaction with o-phenylenediamine or an o-phenylenediamine derivative and a catalyst, and purified to obtain thiabendazole or a thiabendazole derivative; wherein a substituent is grafted onto the thiophene ring and / or the benzene ring in the thiabendazole derivative.
2. The synthesis process of thiabendazole compounds according to claim 1, characterized in that: The carboxylic acid activating agent includes at least one of thionyl chloride, phosphorus chloride, sulfuryl chloride, hydrogen chloride, and sulfuric acid; And / or, the solvent for the esterification treatment includes at least one of methanol, ethanol, and dimethyl sulfoxide; And / or, the temperature of the esterification treatment is 0°C to 65°C, and the reaction time is 4 to 24 hours; And / or, the ratio of the thiazole ring-4-carboxylic acid or the thiazole ring-4-carboxylic acid derivative to the carboxylic acid activating agent is 1 g: (1-2) mL.
3. The synthesis process of thiabendazole compounds according to claim 2, characterized in that: The esterification step comprises: dissolving the thiazole ring-4-carboxylic acid in anhydrous methanol, cooling in an ice bath to 0° C. to 5° C., then dropping the thionyl chloride and mixing for 1 to 2 hours, removing the ice bath and continuing mixing for 4 to 24 hours.
4. The synthesis process of thiabendazole compounds according to any one of claims 1 to 3, characterized in that: The oxidant comprises at least one of manganese dioxide, N-methylmorpholine-N-oxide, and potassium permanganate; and / or, the oxidant is activated at 300° C. to 500° C. before the oxidation treatment is performed; And / or, the solvent for the oxidation treatment includes at least one of acetonitrile, dimethyl sulfoxide, and methanol; And / or, the oxidation treatment temperature is 75°C to 85°C, and the reaction time is 4 to 48 hours; And / or, the molar ratio of the thiazolidine-4-carboxylic acid methyl ester or the thiazolidine-4-carboxylic acid methyl ester derivative to the oxidant is 1:(20-25).
5. The synthesis process of thiabendazole compounds according to claim 4, characterized in that: The oxidation treatment step comprises: dissolving the manganese dioxide activated at 300° C. to 400° C. and the thiazolidine-4-carboxylic acid methyl ester in acetonitrile, reacting at a temperature of 75° C. to 85° C. for 24 to 48 hours, filtering after cooling, removing the solvent in the filtrate, and obtaining the thiazole-4-carboxylic acid methyl ester.
6. The synthesis process of thiabendazole compounds according to any one of claims 1 to 3 or 5, characterized in that: The pH value of the alkaline condition is 7 to 9; And / or, the temperature of the hydrolysis treatment is 20°C to 40°C, and the reaction time is 1 to 2 hours; And / or, the solvent for the hydrolysis treatment includes at least one of methanol and ethanol; And / or, the acidification step includes: adding hydrochloric acid and mixing, and then performing extraction treatment to obtain the thiazole-4-carboxylic acid.
7. The synthesis process of thiabendazole compounds according to claim 6, characterized in that: The extractant used in the extraction treatment includes at least one of diethyl ether, dioxane, and n-hexane; Alternatively, the step of preparing the thiazole-4-carboxylic acid comprises: dissolving the thiazole-4-carboxylic acid methyl ester in methanol, adding 10% by mass of sodium hydroxide to adjust the pH value to 7-9, and then mixing for 1-2 hours, adding concentrated hydrochloric acid and mixing, and extracting and separating the purified product with diethyl ether to obtain the thiazole-4-carboxylic acid.
8. The process for synthesizing thiabendazole compounds according to any one of claims 1 to 3, 5 or 7, characterized in that: The catalyst includes at least one of polyphosphoric acid, pyridine and piperidine; and / or, the molar ratio of the thiazole-4-carboxylic acid or the thiazole-4-carboxylic acid derivative to the o-phenylenediamine or the o-phenylenediamine derivative to the catalyst is 1:(0.8-1.2):(0.5-0.7); And / or, the condensation reaction step comprises: in an inert atmosphere, mixing the o-phenylenediamine and the catalyst, preheating the mixture to 120° C. to 180° C., adding the thiazole-4-carboxylic acid, and heating the mixture to 200° C. to 250° C. for reaction; And / or, the purification step includes: adjusting the pH value of the product of the condensation reaction to 5-6 to precipitate a crude product, dissolving the crude product in an acid solution with a pH value of 1-2 after washing, adding activated carbon for decolorization, adjusting the pH value of the filtrate to 7-8 after filtering, collecting the crystalline product, and obtaining the thiabendazole.
9. The synthesis process of thiabendazole compounds according to claim 8, characterized in that: The yield of the thiabendazole is not less than 85%, and the purity is not less than 99%.
10. A fungicide, characterized in that: The fungicide contains thiabendazole and / or thiabendazole derivatives obtained by the synthesis process according to any one of claims 1 to 9.
